Derive
Input your constraints. We bring in the regulatory, trial, financial and medical data for your indication and trial.
Early-stage teams need to navigate hard constraints, including budget, burn and patient cap. We use these constraints to find the right design for you.
The Trial Design Copilot makes every trade-off explicit. See how each constraint changes the design. Reach design lock faster, with fewer amendments downstream.
Input your constraints. We bring in the regulatory, trial, financial and medical data for your indication and trial.
Every perspective of the trial comes together in one place. Every decision is tracked, so the rationale behind the final design is clear.
CTD-style submissions and geographic expansion, plus protocol drafting, consent, site materials and notifications, with human review and sign-off throughout.
A trial design is never decided by a single team. Our platform surfaces the trade-offs across teams.
Operating characteristics, power, type I error — and the assumptions underneath them.
Precedent designs, guidance, and the questions a reviewer asks first.
Differentiation, and the evidence a partner or payer will ask for.
Endpoints, eligibility, comparator, standard of care.
Sites, enrolment rate, schedule of assessments, and where the timeline slips first.
Cost per arm, per patient, per month — against burn and the next raise.
Statistics wants 96 patients. Funding covers 60. That trade-off needs a decision. We don’t make it for you. We lay out the options, show how much each one costs, and give your CMO and statistician a clear basis for sign-off.
Published trial-design methods and machine-learning research, applied to the decisions that have the greatest influence on clinical programme cost.
We're working with a small group of biotech teams ahead of their next design lock. Leave your email — we'll keep you posted and reach out if there's a fit.
or email us directly — lukas@bf-labs.ai